Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

Elevated Donor Hemoglobin A1c Does Not Impair Early Survival in Cardiac Transplant Recipients.

Read this article at

ScienceOpenPublisherPubMed
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      Orthotopic heart transplantation (OHT) is the gold-standard therapy for end-stage heart failure. An increasing deficit between suitable allograft availability and clinical demand for OHT exists. The role of donor diabetes mellitus (DM) on post-transplant recipient outcomes in OHT is controversial. The purpose of this study was to examine donor hemoglobin A1c (HbA1c) levels to identify the impact of donor glycemic control on recipient survival.

      Related collections

      Author and article information

      Affiliations
      [1 ] Department of Surgery, Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Durham, North Carolina.
      [2 ] Duke University School of Medicine, Durham, North Carolina.
      Journal
      Clin Transplant
      Clinical transplantation
      Wiley-Blackwell
      1399-0012
      0902-0063
      May 03 2017
      28470781
      10.1111/ctr.12995

      Comments

      Comment on this article